Last reviewed · How we verify
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of troxacitabine in treating patients who have blast phase chronic myelogenous leukemia.
Details
| Lead sponsor | Shire |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 31 |
| Start date | Mon Dec 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Mar 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Leukemia
Interventions
- troxacitabine
Countries
Canada, United States